Quantitation of CD55 and CD59 expression on reticulocytes and mature erythrocytes in paroxysmal nocturnal hemoglobinuria, aplastic anemia, and healthy control subjects

Annals of Clinical and Laboratory Science

Volumn 40, Issue 3, 2010, Pages 226-232

  Kim, Yeongsic ^a   Lim, Jihyang ^a   Kim, Myungshin ^a   Kim, Yonggoo ^a   Lee, Jong Wook ^a   Han, Kyungja ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Aplastic anemia; CD55; CD59; Paroxysmal nocturnal hemoglobinuria

Indexed keywords

CD59 ANTIGEN; DECAY ACCELERATING FACTOR; HEMOGLOBIN; LACTATE DEHYDROGENASE; MONOCLONAL ANTIBODY; THIAZOLE ORANGE;

ADULT; APLASTIC ANEMIA; ARTICLE; BLOOD CELL COUNT; CELL POPULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIFFERENTIAL DIAGNOSIS; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RETICULOCYTE; RETICULOCYTE COUNT;

ADULT; ANEMIA, APLASTIC; ANTIGENS, CD55; ANTIGENS, CD59; CASE-CONTROL STUDIES; ERYTHROCYTE COUNT; ERYTHROCYTES; FEMALE; FLOW CYTOMETRY; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; RETICULOCYTES; YOUNG ADULT;

EID: 77955835650     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kinoshita T, Inoue N. Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria. Int J Hematol 2002;75:117-122.
2. Dunn DE, Tanawattanacharoen P, Boccuni P, Nagakura S, Gree SW, Kirby MR, et al. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med 1999;131:401-408.
3. Young NS, Maciejewski JP, Sloand E, Chen G, Zeng W, Risitano A, et al. The relationship of aplastic anemia and PNH. Int J Hematol 2002;76(Suppl 2):168-172.
4. Okamoto M, Shichishima T, Noji H, Ikeda K, Nakamura A, Akutsu K, et al. High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome. Leukemia 2006;20:627-634.
5. Wanachiwanawin W, Siripanyaphinyo U, Piyawattanasakul N, Kinoshita T. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia. Eur J Haematol 2006;76:502-509.
6. Azenishi Y, Ueda E, Machii T, Nishimura J, Hirota T, Shibano M, Nakao S, Kinoshita T, et al. CD59-deficient blood cells and PIG-A gene abnormalities in Japanese patients with aplastic anaemia. Br J Haematol 1999;104: 523-529.
7. Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005;106: 3699-709.
8. Richards SJ, Rawstron AC, Hillmen P. Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry 2000;42:223-233.
9. Scott JL, Cartwright GE, Wintrobe MM. Acquired aplastic anemia: an analysis of thirty-nine cases and review of the pertinent literature. Medicine 1959:38:119-172.
10. Issaragrisil S, Kaufman DW, Anderson T, Changsung K, Leaverton PE, Shapiro S, et al. The epidemiology of aplastic anemia in Thailand. Blood 2006;107:1299-1307.
11. Holguin MH, Wilcox LA, Bernshaw NJ, Rosse WF, Parker CJ. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 1989;84:1387-1394.
12. Endo M, Ware RE, Vreeke TM, Singh SP, Howard TA, Tomita A, et al. Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria. Blood 1996;87:2546-2557.
13. Ferreira VP, Pangburn MK. Factor H-mediated cell surface protection from complement is critical for the survival of PNH erythrocytes. Blood 2007;110:2190-2192.
14. Ueda E, Kinoshita T, Terasawa T, Shichishima T, Yawata Y, Inoue K, Kitani T. Acethylcholinesterase and lymphocyte function-associated antigen 3 found on decay-accelerating factor-negative erythrocytes from some patients with paroxysmal nocturnal hemoglobinuria are lost during erythrocyte aging. Blood 1990;75:762-769.
15. Navenot JM, Muller JY, Blanhard D. Investigation of the survival of paroxysmal nocturnal hemoglobinuria red cells through the immunophenotyping of reticulocytes. Transfusion 1998;38:337-342.
16. Wang H, Chuhjo T, Yamazaki H, Shiobara S, Teramura M, Mizoguchi H, et al. Relatve increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients: the high prevalence at diagnosis. Eur J Haematol 2001;66:200-205.
17. Mortazavi Y, Merk B, Mclntosh J, Marsh JC, Schrezenmeier H, Rutherford TR. The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): a high incidence of multiple mutations and evidence of a mutational hot spot. Blood 2003;101:2833-2841.
18. Cui W, Lin Q, Zhang Z. Phenotypic analysis of affected peripheral erythroid for CD59 in paroxysmal nocturnal hemoglobinuria. Chin Med J 2002;115:206-208.
19. Sato S, Hasegawa Y, Nagasawa T, Ninomiya H. Reticulocyte-gated flow cytometric analysis of red blood cells in paroxysmal nocturnal hemoglobinuria. Lab Hematol 2006;12:82-85.
20. Ware RE, Rosse WF, Hall SE. Immunophenotypic analysis of reticulocytes in paroxysmal nocturnal hemoglobinuria. Blood 1995;86:1586-1589.